Susan O’Brien
Professor of Medicine at the University of California, Irvine, CA
Best podcasts with Susan O’Brien
Ranked by the Snipd community
Jul 31, 2020 • 44min
The CLL Sessions: frontline therapy, BTK inhibitors, MRD negativity & novel therapies
Experts Barbara Eichhorst, Susan O’Brien, and Matthew Davids discuss frontline therapy, BTK inhibitors, MRD negativity, novel therapies, CLL14 trial updates, debulking strategies, achieving MRD negativity, triple combination therapies, sequencing in CLL treatment, non-covalent BTK inhibitors, and ongoing studies in CLL treatment.
